CasNo.763114-26-7,2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid,(763114-26-7) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 98%min
Payment Terms : L/C,T/T,Other

Keywords

763114-26-7 Sell High quality 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid 763114-26-7 factory direct supply high assay 763114-26-7

Quick Details

Appearance:white or light yellow crystalline powder
Application:Used for research and industrial manufacture.
PackAge:As customer request
ProductionCapacity:100|Kilogram|Week
Storage:Store in a cool,dry place and keep away from direct strong light
Transportation:By Sea/Air/Courier

Superiority:

Details:

Custom Synthesis Trading(Raw Material Sourcing)

(1)Small Molecule Compounds (1)API/Intermediates

(2)medicinal chemistry and drug discovery (2) Cosmetic materials

(3)Heterocyclic Chemistry (3) Food Additives

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid 763114-26-7

Adenine Olaparib

Brand Nutrabiotech

2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid
CAS: 763114-26-7
MF: C16H11FN2O3
MW: 298.2685432

Function of Olaparib
Olaparib as a maintenance therapy or monotherapy for the treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. On January 12, 2018, FDA expanded the approved use of Olaparib to include chemotherapy-experienced patients with germline breast cancer susceptibility gene (BRCA) mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.